Publications by authors named "A A al-Zubaidy"

Article Synopsis
  • Alzheimer's disease leads to a decline in cognitive and behavioral functions, and the study examined the neuroprotective effects of amifostine, a drug with anti-inflammatory and antioxidant properties, in a mouse model of the disease.
  • The experiment involved four groups of mice, with one group receiving scopolamine to induce cognitive impairment, while the other groups received either donepezil or amifostine to evaluate their protective effects.
  • Results showed that amifostine improved cognitive performance and reduced signs of neurotoxicity, inflammation, and oxidative stress, suggesting it could help protect against Alzheimer's-related damage.
View Article and Find Full Text PDF

Psoriasis is a life-long immune-mediated dermatosis with thickened, reddish, and flaky skin patches. Canagliflozin is a gliflozin antidiabetic with non-classical remarkable antioxidative, anti-inflammatory, anti-proliferative, and immune-modulating effects. The aim of this study is to examine the probable effects of topical canagliflozin on a mouse model of imiquimod-provoked psoriasis-like dermatitis.

View Article and Find Full Text PDF

Background: Famotidine is a competitive histamine H-receptor antagonist that reduces the formation of stomach acid and is used to treat gastrointestinal disorders associated with acid reflux, gastroesophageal reflux disease, duodenal ulcer, gastric ulcer, and pathological hypersecretory disorders. This study is designed to investigate the possible neuroprotective effects of the ranolazine scopolamine-induced Alzheimer's disease-like feature in a mouse model.

Methods: Mice were divided equally into five groups (ten mice per group), including control group and induction group.

View Article and Find Full Text PDF

This study assesses the potential positive impact of a 0.05% isoxsuprine ointment on psoriasiform skin inflammation generated by imiquimod in mouse models. Thirty-two male albino mice were allocated into four groups: the control group (which received topical emollients twice daily for 16 days), the induction group (which received imiquimod cream (5%) for 8 days, twice daily followed by petrolatum gel (15%) for another 8 days), and the other two groups, which received imiquimod cream (5%) for 8 days followed by either clobetasol ointment (0.

View Article and Find Full Text PDF

Psoriasis is a long-lasting, immune-related inflammatory skin disease that affects 2-3% of the global population. It is distinguished by erythematous, silvery, and scaly patches. Ramelteon is a type of melatonin agonist that is used to treat insomnia.

View Article and Find Full Text PDF